View source for Open-Source Drug Development

'''Open-source drug development''' is an approach to pharmaceutical research in which data, compounds, and methodologies are shared openly among researchers, enabling distributed collaboration and reducing the duplication of effort that characterizes proprietary drug discovery. The model draws on the success of open-source software development, applying its principles of transparent repositories, peer review, and modular contribution to the problem of developing therapeutics for neglected diseases.

The approach is particularly suited to diseases where the commercial incentive is absent but the scientific knowledge is cumulative. By sharing chemical libraries, assay results, and clinical data, open-source development prevents the positive feedback of proprietary concentration and creates a different kind of positive feedback: shared knowledge attracts more researchers, which generates more knowledge, which attracts more researchers. This is the same [[Network Effect|network effect]] that drives open-source software, applied to molecular biology.

See also [[Drugs for Neglected Diseases initiative]] and [[Product Development Partnership|product development partnerships]].

[[Category:Systems]] [[Category:Medicine]] [[Category:Technology]]